# MAPK8IP1

## Overview
MAPK8IP1 is a gene that encodes the protein mitogen-activated protein kinase 8 interacting protein 1, commonly referred to as JIP-1 or islet-brain-1 (IB1). JIP-1 is a scaffold protein that plays a crucial role in the c-Jun NH2-terminal kinase (JNK) signaling pathway, which is involved in cellular stress responses, apoptosis, and cytokine signaling. The protein is characterized by several functional domains, including a JNK-binding domain, a phosphotyrosine-binding domain, and an Src homology 3 (SH3) domain, which facilitate its interactions with various signaling molecules (Waeber2000The; Negri2000cDNA). JIP-1 is predominantly expressed in the brain and pancreatic β-cells, where it is involved in processes such as neuronal transport and insulin secretion (Waeber2000The; Fu2014MAPK8IP1JIP1). Alterations in MAPK8IP1 expression or function have been linked to several diseases, including Alzheimer's disease, gastric cancer, and type 2 diabetes, highlighting its clinical significance (Waeber2000The; Helbecque2003Isletbrain1CJun; Lu2016Direct).

## Structure
The MAPK8IP1 gene encodes the islet-brain-1 (IB1) protein, also known as JIP-1, which is a scaffold protein involved in the c-Jun NH2-terminal kinase (JNK) signaling pathway. The primary structure of IB1 includes several functional domains, such as a JNK-binding domain, which facilitates its interaction with JNK, and a phosphotyrosine-binding domain, which may be involved in protein-protein interactions (Waeber2000The; Negri2000cDNA). The protein also contains an Src homology 3 (SH3) domain, which is typically involved in the binding of proline-rich sequences (Negri2000cDNA).

IB1 is known to undergo post-translational modifications, including phosphorylation, which can affect its function and interactions within the JNK signaling pathway (Negri2000cDNA). The protein can form complexes with other proteins, indicating a quaternary structure that is crucial for its role as a scaffold in signaling pathways (Negri2000cDNA).

Splice variants of MAPK8IP1 may exist, leading to different isoforms with potentially distinct functions, although specific details on these variants are not provided in the context (Negri2000cDNA). The gene is expressed predominantly in the brain and pancreatic β-cells, where it plays a protective role against apoptosis (Waeber2000The).

## Function
MAPK8IP1, also known as JIP-1, is a scaffold protein that plays a significant role in the JNK signaling pathway, which is involved in cellular responses to stress, apoptosis, and cytokines. JIP-1 interacts with multiple components of the JNK pathway, including MAP kinase kinase MKK7 and MAP kinase JNK, enhancing JNK activation by the MLK signaling pathway (Whitmarsh1998A). It forms a large oligomeric complex or signalosome, incorporating various MAP kinases such as JNK, TAK1, TAB1, and MKK7, which is crucial for the assembly and modulation of signaling pathways (Blanco2008Modulation).

In neurons, JIP-1 is essential for the transport of autophagosomes, ensuring their retrograde movement in axons, which is vital for their fusion with lysosomes and the clearance of damaged organelles, thus preventing neurodegenerative diseases (Fu2014MAPK8IP1JIP1). JIP-1 also interacts with kinesin and the Alzheimer's amyloid precursor protein, indicating its role in axonal transport and neuronal cell function (Helbecque2003Isletbrain1CJun).

In beta-cells, JIP-1 is involved in insulin secretion by interacting with JNK and kinesin, affecting the trafficking of insulin vesicles. JIP-1 deficiency leads to decreased glucose-stimulated insulin secretion, highlighting its importance in metabolic regulation (barutcu2018role).

## Clinical Significance
Mutations and alterations in the expression of the MAPK8IP1 gene have been implicated in several diseases. In gastric cancer, MAPK8IP1 expression is significantly reduced, and its downregulation is associated with increased metastasis. This is primarily due to the direct targeting of MAPK8IP1 by miR-10a, which enhances cell invasion and migration, contributing to the metastatic behavior of gastric cancer cells (Lu2016Direct).

In Alzheimer's disease (AD), a specific polymorphism in the MAPK8IP1 promoter, -499A>G, has been linked to an increased risk of AD, particularly in individuals with certain genotypes of the LRP gene. This polymorphism enhances the promoter's activity, potentially affecting the expression of proteins involved in neurofibrillary tangles, a hallmark of AD (Helbecque2003Isletbrain1CJun).

MAPK8IP1 is also considered a candidate gene for type 2 diabetes (T2D). A missense mutation, S59N, in MAPK8IP1 has been identified in a family with T2D, impairing the protein's ability to prevent insulin expression loss due to JNK pathway activation. This mutation is associated with altered β-cell function and increased susceptibility to apoptosis, contributing to the development of diabetes (Waeber2000The).

## Interactions
MAPK8IP1, also known as JIP-1, is a scaffold protein that interacts with various components of the JNK signaling pathway. It preferentially binds to the MAP kinase kinase MKK7 and the MAP kinase JNK, as well as the mixed-lineage kinases MLK3 and DLK, which are part of the MAP kinase kinase kinase (MAPKKK) group (Whitmarsh1998A). JIP-1 also interacts with the hematopoietic progenitor kinase-1 (HPK1), a Ste20p-related protein kinase, but not with PAK3 or the Rho family proteins Cdc42 or Rac1 (Whitmarsh1998A). 

JIP-1 binds directly to JNK1 and JNK2, with a higher affinity than to transcription factors ATF2 and c-Jun, and inhibits the phosphorylation of c-Jun by JNK, suggesting a regulatory role in the JNK signaling pathway (Dickens1997A). It also interacts with the Alzheimer's amyloid precursor protein (APP), associating APP with JNK via JIP-1 (Matsuda2001cJun). 

In neurons, MAPK8IP1 regulates the transport of autophagosomes by interacting with kinesin-1 heavy chain (KIF5/KHC) and the DCTN1/p150 Glued subunit of dynactin, coordinating motor activity for retrograde transport along the axon (Fu2014MAPK8IP1JIP1).


## References


[1. (Lu2016Direct) Yaoyong Lu, Ganbao Wei, Liangbo Liu, Yichao Mo, Qingsheng Chen, Lufei Xu, Rongwei Liao, Dehao Zeng, and Kunqiang Zhang. Direct targeting of mapk8ip1 by mir-10a-5p is a major mechanism for gastric cancer metastasis. Oncology Letters, 13(3):1131–1136, December 2016. URL: http://dx.doi.org/10.3892/ol.2016.5544, doi:10.3892/ol.2016.5544. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2016.5544)

[2. (Fu2014MAPK8IP1JIP1) Meng-meng Fu and Erika L F Holzbaur. Mapk8ip1/jip1 regulates the trafficking of autophagosomes in neurons. Autophagy, 10(11):2079–2081, October 2014. URL: http://dx.doi.org/10.4161/auto.34451, doi:10.4161/auto.34451. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.4161/auto.34451)

[3. (Matsuda2001cJun) Shuji Matsuda, Takashi Yasukawa, Yasuko Homma, Yuko Ito, Takako Niikura, Takako Hiraki, Shuichi Hirai, Shigeo Ohno, Yoshiko Kita, Masaoki Kawasumi, Keisuke Kouyama, Tokuo Yamamoto, John M. Kyriakis, and Ikuo Nishimoto. C-jun n-terminal kinase (jnk)-interacting protein-1b/islet-brain-1 scaffolds alzheimer’s amyloid precursor protein with jnk. The Journal of Neuroscience, 21(17):6597–6607, September 2001. URL: http://dx.doi.org/10.1523/jneurosci.21-17-06597.2001, doi:10.1523/jneurosci.21-17-06597.2001. This article has 142 citations.](https://doi.org/10.1523/jneurosci.21-17-06597.2001)

[4. (Negri2000cDNA) Stéphanie Negri, Anne Oberson, Myriam Steinmann, Christelle Sauser, Pascal Nicod, Gérard Waeber, Daniel F. Schorderet, and Christophe Bonny. Cdna cloning and mapping of a novel islet-brain/jnk-interacting protein. Genomics, 64(3):324–330, March 2000. URL: http://dx.doi.org/10.1006/GENO.2000.6129, doi:10.1006/geno.2000.6129. This article has 84 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/GENO.2000.6129)

[5. (Dickens1997A) Martin Dickens, Jeffrey S. Rogers, Julie Cavanagh, Art Raitano, Zhengui Xia, Jocelyn R. Halpern, Michael E. Greenberg, Charles L. Sawyers, and Roger J. Davis. A cytoplasmic inhibitor of the jnk signal transduction pathway. Science, 277(5326):693–696, August 1997. URL: http://dx.doi.org/10.1126/science.277.5326.693, doi:10.1126/science.277.5326.693. This article has 531 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.277.5326.693)

6. (barutcu2018role) Role of JIP1-JNK Signaling in Beta-Cell Function and Autophagy. This article has 0 citations.

[7. (Helbecque2003Isletbrain1CJun) N Helbecque, A Abderrhamani, L Meylan, B Riederer, V Mooser, J Miklossy, J Delplanque, P Boutin, P Nicod, J-A Haefliger, D Cottel, P Amouyel, P Froguel, and G Waeber. Islet-brain1/c-jun n-terminal kinase interacting protein-1 (ib1/jip-1) promoter variant is associated with alzheimer’s disease. Molecular Psychiatry, 8(4):413–422, April 2003. URL: http://dx.doi.org/10.1038/sj.mp.4001344, doi:10.1038/sj.mp.4001344. This article has 30 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.mp.4001344)

[8. (Waeber2000The) Gérard Waeber, Jérôme Delplanque, Christophe Bonny, Vincent Mooser, Myriam Steinmann, Christian Widmann, Anne Maillard, Judith Miklossy, Christian Dina, El H Hani, Gérard Waeber, Jérôme Delplanque, Nathalie Vionnet, Pascal Nicod, Philippe Boutin, and Philippe Froguel. The gene mapk8ip1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nature Genetics, 24(3):291–295, March 2000. URL: http://dx.doi.org/10.1038/73523, doi:10.1038/73523. This article has 147 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/73523)

[9. (Blanco2008Modulation) Sandra Blanco, Marta Sanz-García, Claudio R. Santos, and Pedro A. Lazo. Modulation of interleukin-1 transcriptional response by the interaction between vrk2 and the jip1 scaffold protein. PLoS ONE, 3(2):e1660, February 2008. URL: http://dx.doi.org/10.1371/journal.pone.0001660, doi:10.1371/journal.pone.0001660. This article has 58 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0001660)

[10. (Whitmarsh1998A) Alan J. Whitmarsh, Julie Cavanagh, Cathy Tournier, Jun Yasuda, and Roger J. Davis. A mammalian scaffold complex that selectively mediates map kinase activation. Science, 281(5383):1671–1674, September 1998. URL: http://dx.doi.org/10.1126/science.281.5383.1671, doi:10.1126/science.281.5383.1671. This article has 521 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.281.5383.1671)